DHC director receives 12,401-share equity award

Hollis Phyllis M. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Hollis Phyllis M. reported acquisition or exercise transactions in this Form 4 filing.

Diversified Healthcare Trust director Phyllis M. Hollis received an award of 12,401 Common Shares of Beneficial Interest on June 10, 2026 under the company’s equity compensation plan. The award was granted at no cash cost per share as part of her director compensation.

After this grant, she directly holds 100,147.703 common shares. This total includes 666.634 shares accumulated through a dividend reinvestment plan since her prior Section 16 filing, showing ongoing participation in the company’s reinvestment program in addition to the new equity award.

Insider Trade Summary

Grant/Award: 12,401 shares

Grant/Award 1 txn

Insider Hollis Phyllis M.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares of Beneficial Interest	12,401	$0.00	$0.00

Holdings After Transaction: Common Shares of Beneficial Interest — 100,147.703 shares (Direct)

Footnotes (2)

1. F1. Transaction reported is award of shares pursuant to the Issuer's equity compensation plan.
2. F2. Includes 666.634 shares acquired under a dividend reinvestment plan since the last Section 16 filing by Ms. Hollis.

Key Figures

Equity award: 12,401 shares Holdings after transaction: 100,147.703 shares Dividend reinvestment plan shares: 666.634 shares

3 metrics

Equity award 12,401 shares Common Shares of Beneficial Interest granted on June 10, 2026

Holdings after transaction 100,147.703 shares Directly held common shares following the grant

Dividend reinvestment plan shares 666.634 shares Shares accumulated via dividend reinvestment since prior Section 16 filing

Key Terms

equity compensation plan, dividend reinvestment plan, Section 16 filing

3 terms

equity compensation plan financial

"Transaction reported is award of shares pursuant to the Issuer's equity compensation plan."

A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.

dividend reinvestment plan financial

"Includes 666.634 shares acquired under a dividend reinvestment plan since the last Section 16 filing"

A dividend reinvestment plan lets shareholders automatically use cash dividends to buy more shares of the same company instead of receiving the money. It matters to investors because it turns regular payouts into a steady way to grow ownership and take advantage of compound returns—like having your savings automatically buy additional slices of a pie over time—while often reducing transaction costs and smoothing purchase timing.

Section 16 filing regulatory

"since the last Section 16 filing by Ms. Hollis"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did DHC director Phyllis M. Hollis report?

Phyllis M. Hollis reported receiving an award of 12,401 common shares of Beneficial Interest in Diversified Healthcare Trust. The shares were granted at no cash cost under the company’s equity compensation plan as part of her director compensation.

How many DHC shares does Phyllis M. Hollis hold after this Form 4?

After the reported transaction, Phyllis M. Hollis directly holds 100,147.703 common shares of Beneficial Interest in Diversified Healthcare Trust. This figure reflects both the new equity award and shares accumulated through the company’s dividend reinvestment plan.

Was the DHC share award to Phyllis M. Hollis an open-market purchase?

No, the 12,401 DHC shares were not an open-market purchase. They were granted to Phyllis M. Hollis as an equity award under the company’s compensation plan, with a reported price of $0.0000 per share on the Form 4.

Does the Form 4 for DHC show any insider share sales by Phyllis M. Hollis?

The Form 4 does not report any share sales by Phyllis M. Hollis. It discloses only an acquisition coded as a grant or award of 12,401 common shares, plus updated holdings that include dividend reinvestment plan shares.

What role does the dividend reinvestment plan play in Phyllis M. Hollis’s DHC holdings?

The filing notes that 666.634 of Phyllis M. Hollis’s DHC shares were acquired through a dividend reinvestment plan. This means dividends on existing holdings were automatically used to buy additional shares, increasing her total position over time.

Is the DHC equity award to Phyllis M. Hollis part of a compensation plan?

Yes, the transaction is explicitly described as an award of shares under Diversified Healthcare Trust’s equity compensation plan. Such awards are a common way to compensate directors with stock rather than cash, aligning their interests with shareholders.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 04:19 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hollis Phyllis M.

(Last) (First) (Middle)

C/O THE RMR GROUP LLC

TWO NEWTON PL., 255 WASH. ST., STE. 300

(Street)

NEWTON MASSACHUSETTS 02458

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DIVERSIFIED HEALTHCARE TRUST [ NASDAQ:DHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares of Beneficial Interest	06/10/2026		A		12,401	A	(1)	100,147.703(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction reported is award of shares pursuant to the Issuer's equity compensation plan.

2. Includes 666.634 shares acquired under a dividend reinvestment plan since the last Section 16 filing by Ms. Hollis.

	/s/ Phyllis M. Hollis	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)